Search research articles
Contact Us
Filters
Showing results (1-10 of 207) with videos related to
Page
of 21
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 13, 2014
Editorial commentary: protease inhibitor monotherapy: safe for the CNS in durably suppressed patients?
Scott L Letendre
The Journal of Infectious Diseases
|
March 17, 2026
Pushing the Stone Uphill Together
Scott L Letendre
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 8, 2016
Update and New Directions in Therapeutics for Neurological Complications of HIV Infections
Ronald Ellis, Scott L Letendre
Topics in Antiviral Medicine
|
May 29, 2019
CROI 2019: neurologic complications of HIV disease
Beau M Ances, Scott L Letendre
The Journal of Infectious Diseases
|
November 17, 2006
Is the glass three-quarters full or one-quarter empty?
Justin C McArthur, Scott L Letendre
International Journal of Molecular Sciences
|
February 11, 2023
Time of Day Influences Concentrations of Total Protein and Albumin in Cerebrospinal Fluid in HIV
Visesha Kakarla, Scott L Letendre, Ronald J Ellis
AIDS (London, England)
|
October 3, 2020
Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system
Dana Gabuzda, Justin C McArthur, Scott L Letendre
Topics in Antiviral Medicine
|
January 2, 2025
CROI 2024: Neuropsychiatric Complications in People With HIV
Michael J Corley, Scott L Letendre, Sam Nightingale
Topics in Antiviral Medicine
|
June 9, 2021
CROI 2021: Neurologic Complications of HIV-1 Infection or COVID-19
Beau M Ances, Albert M Anderson, Scott L Letendre
Topics in Antiviral Medicine
|
November 8, 2022
CROI 2022: neurologic complications of HIV-1, SARS-CoV-2, and other pathogens
Albert M Anderson, Scott L Letendre, Beau M Ances
Page
of 21
Search research articles
Search
Showing results (1-10 of 207) with videos related to
Sort By:
Page
of 21
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 13, 2014
Editorial commentary: protease inhibitor monotherapy: safe for the CNS in durably suppressed patients?
Scott L Letendre
The Journal of Infectious Diseases
|
March 17, 2026
Pushing the Stone Uphill Together
Scott L Letendre
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 8, 2016
Update and New Directions in Therapeutics for Neurological Complications of HIV Infections
Ronald Ellis, Scott L Letendre
Topics in Antiviral Medicine
|
May 29, 2019
CROI 2019: neurologic complications of HIV disease
Beau M Ances, Scott L Letendre
The Journal of Infectious Diseases
|
November 17, 2006
Is the glass three-quarters full or one-quarter empty?
Justin C McArthur, Scott L Letendre
International Journal of Molecular Sciences
|
February 11, 2023
Time of Day Influences Concentrations of Total Protein and Albumin in Cerebrospinal Fluid in HIV
Visesha Kakarla, Scott L Letendre, Ronald J Ellis
AIDS (London, England)
|
October 3, 2020
Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system
Dana Gabuzda, Justin C McArthur, Scott L Letendre
Topics in Antiviral Medicine
|
January 2, 2025
CROI 2024: Neuropsychiatric Complications in People With HIV
Michael J Corley, Scott L Letendre, Sam Nightingale
Topics in Antiviral Medicine
|
June 9, 2021
CROI 2021: Neurologic Complications of HIV-1 Infection or COVID-19
Beau M Ances, Albert M Anderson, Scott L Letendre
Topics in Antiviral Medicine
|
November 8, 2022
CROI 2022: neurologic complications of HIV-1, SARS-CoV-2, and other pathogens
Albert M Anderson, Scott L Letendre, Beau M Ances
Page
of 21